Consistently, flow cytometry analysis also demonstrated that P-EVs treatment upregulated SLC7A11 expression in NPC cells parallelly with an increase in ITGB3 expression (Figure 4B). This evidence concerns the gene ITGB3 and nasopharyngeal carcinoma.